Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

101 results about "Blood sugar regulation" patented technology

Blood sugar regulation is the process by which the levels of blood sugar, primarily glucose, are maintained by the body within a narrow range. This tight regulation is referred to as glucose homeostasis. Insulin, which lowers blood sugar, and glucagon, which raises it, are the most well known of the hormones involved, but more recent discoveries of other glucoregulatory hormones have expanded the understanding of this process.

Micro-needle patch capable of intelligently regulating blood glucose and preparation method thereof

ActiveCN108837299AHigh mechanical strengthRealize painless minimally invasive puncturePowder deliveryPeptide/protein ingredientsCentrifugationMedicine
The invention discloses a micro-needle patch capable of intelligently regulating blood glucose and a preparation method thereof, and belongs to the field of biomedicine. An intelligent micro-needle part of the micro-needle patch capable of adjusting blood glucose is filled with a medicine for intelligently adjusting blood glucose, and the medicine comprises a carrier material, glucose response sensitive switch factors and medicine molecules. A micro-needle of a micro-needle template is filled with a hydrogel solution containing the medicine through a vacuumizing and centrifugation method; re-centrifugation is carried out, a base of the micro-needle patch is prepared by using the hydrogel solution without the medicine, solidification of the hydrogel material is carried out through a propermethod, and after drying, the micro-needle patch is stripped from the template to obtain the micro-needle patch for intelligently adjusting the blood glucose. The micro-needle patch can puncture skin,insulin is intelligently released in the body according to the blood glucose concentration, and the blood glucose level is intelligently adjusted. According to the micro-needle patch, painless and intelligent response type blood glucose regulation is realized, and diabetes diagnosis and treatment integration is expected to be guided.
Owner:WUHAN UNIV

3D printing microneedle patch for intelligent blood sugar regulation and a preparation method thereof

The invention discloses a 3D printing microneedle patch for intelligent blood glucose regulation and a preparation method thereof, belonging to the biomedical field. The 3D printing microneedle patchof the invention is mainly made of photosensitive material with good biocompatibility, and comprises two parts of a substrate and a microneedle array, wherein the microneedle array comprises a plurality of conical microneedles, and the microneedles contain medicaments for intelligently regulating blood sugar, and the medicaments include carrier materials, glucose-responsive sensitive switching factors and medicaments molecules. The 3D printing microneedle patch of the invention is mainly made of photosensitive material with good biocompatibility. Firstly, the three-dimensional model of micro-needle patch is built by using modeling software, and the model is imported into the printing software of 3D printer. Then the 3D printing technology of photocuring is used to solidify the photosensitive material solution containing photoinitiator and drug according to the structure of the three-dimensional model of the micro-needle patch to obtain the 3D printing micro-needle patch. The microneedle patch of the invention can puncture the skin and intelligently release the loaded insulin according to the blood glucose concentration in the body so as to intelligently regulate the blood glucose level. The invention realizes painless, intelligent and responsive blood glucose regulation.
Owner:WUHAN UNIV

Retrospective retrofitting method to generate a continuous glucose concentration profile by exploiting continuous glucose monitoring sensor data and blood glucose measurements

Continuous Glucose Monitoring (CGM) devices provide glucose concentration measurements in the subcutaneous tissue with limited accuracy and precision. Therefore, CGM readings cannot be incorporated in a straightforward manner in outcome metrics of clinical trials e.g. aimed to assess new glycaemic-regulation therapies. To define those outcome metrics, frequent Blood Glucose (BG) reference measurements are still needed, with consequent relevant difficulties in outpatient settings. Here we propose a “retrofitting” algorithm that produces a quasi continuous time BG profile by simultaneously exploiting the high accuracy of available BG references (possibly very sparsely collected) and the high temporal resolution of CGM data (usually noisy and affected by significant bias). The inputs of the algorithm are: a CGM time series; some reference BG measurements; a model of blood to interstitial glucose kinetics; and a model of the deterioration in time of sensor accuracy, together with (if available) a priori information (e.g. probabilistic distribution) on the parameters of the model. The algorithm first checks for the presence of possible artifacts or outliers on both CGM datastream and BG references, and then rescales the CGM time series by exploiting a retrospective calibration approach based on a regularized deconvolution method subject to the constraint of returning a profile laying within the confidence interval of the reference BG measurements. As output, the retrofitting algorithm produces an improved “retrofitted” quasi-continuous glucose concentration signal that is better (in terms of both accuracy and precision) than the CGM trace originally measured by the sensor. In clinical trials, the so-obtained retrofitted traces can be used to calculate solid outcome measures, avoiding the need of increasing the data collection burden at the patient level.
Owner:DEXCOM

Bitter melon tea and preparation method thereof

InactiveCN101467569AIngredients coordinationFlavor fusionPre-extraction tea treatmentFood preparationSide effectAdditive ingredient
The bitter gourd tea is composed of 45-50% of bitter gourd powder, 15-20% of mulberry leaves, 10-15% of astragalus root, 10-15% of green tea and 5-10% of black tea by weight. The production process is as follows: 1) high-quality fresh bitter gourd is chosen as raw material and produced into bitter gourd powder after dehydration by cryogenic technique; 2) well-chosen mulberry leaves, astragalus root, green tea and black tea are purified, cleaned, dried and grinded into powder; 3) the above-mentioned powders are evenly mixed according to the weight percentage, sealed in bags or cans. In the bitter gourd tea, the bitter gourd as the main raw material contains charantin which is a hypoglycemic component, proteinoid active substance and multiple amino acids, so has health-care functions of blood sugar regulation, diabetes complication prevention and cure and alcoholism prevention. The bitter gourd tea has advantages of coordinated ingredients, amalgamated taste, convenient eating and no toxic and side effects.
Owner:沃德(天津)营养保健品有限公司

Method for enriching 2-diabetes mellitus target inhibitor from liquorice residue and medical application

InactiveCN107510710ASignificant activity inhibitionReasonable combination designAntipyreticMetabolism disorderPolyamideSolvent
The invention belongs to the technical field of medicines and provides a method for adsorbing, purifying and acquiring liquorice residue total flavone with clear component, clear structure, high active substance content and high activity from liquorice residue after extracting glycyrrhizic acid by using macroporous resin as a main material (above 50%), polyamide as an auxiliary material and a compound adsorbing material prepared from one or two MCI mixed at different ratio according to a compound adsorbing purifying method and a medical application thereof at the aspects of blood sugar regulation, liver injury protection, blood lipids regulation, tumor growth suppression, and the like. According to the invention, various adsorbing materials are reasonably combined and designed and the adsorbing purifying technical operation is simple and feasible; the solvent use is safe, environment-friendly and economical; and the liquorice residue total flavone has an obvious restraining effect for two important targets, namely, alpha-glucosidase and PTP1B for preventing and controlling 2-diabetes mellitus, and especially, the restraining effect strength for alpha-glucosidase is at least 10 times higher than that of clinic hypoglycemic drug acarbose.
Owner:SHENYANG PHARMA UNIVERSITY

Preparation method and application of 3D print microacupuncture needle paster

The invention discloses a preparation method and application of a 3D print microacupuncture needle paster, and belongs to the field of biomaterials and biological manufacturing. A dual-spray-head melting deposition shaping FDM 3D printer is used, a spray head is used for printing a base of the microacupuncture needle paster, and the other spray head is used for printing a columnar array of the microacupuncture needle paster, wherein the columnar array contains insulin medicines which can intelligently respond to and adjust blood sugar. After the base and the columnar array are obtained, a slide is in contact with the top end of the columnar array, then the top end is stretched to a preset distance to produce a needle point of the microacupuncture needle, cross-linking shaping is performed,and after dewatering and drying are completed under natural state, a microacupuncture needle array paster having certain mechanical properties and containing responsiveness medicines is formed. The microacupuncture needle paster can puncture skin, can intelligently respond according to blood sugar concentration in vivo, can intelligently release loaded medicines, and can intelligently adjust thelevel of the blood sugar. In a 3D print microacupuncture needle manner, painless intelligent response type blood sugar adjustment capable of realizing skin puncture can be realized, and the 3D print microacupuncture needle paster hopefully guides diagnosis and treatment integration of diabetes.
Owner:WUHAN UNIV

Novel application of luffa seeds

The invention belongs to the field of medicine and foods and relates to novel application of luffa seeds. The invention provides novel application of the luffa seeds to preparation of a medicament for treating and preventing diabetes mellitus and complications thereof. A blood sugar regulation medicinal composition or preparation can be prepared from the luffa seeds and one or more vectors or excipients which are acceptable on medicaments. Clinical experiments prove that the luffa seeds or luffa seed capsules can be used in combination with other blood sugar regulation medicaments and the effect of combining the luffa seeds or the luffa seed capsules and other blood sugar regulation medicaments is more obvious than that of separately using the blood sugar regulation medicaments; separate use of the luffa seeds or the luffa seed capsules can also obviously reduce blood sugar of a patient and the medicinal effect of the luffa seeds or the luffa seed capsules is more obvious that that of a common chemical synthetic medicament for preventing diabetes mellitus; administration of the luffa seeds or the luffa seed capsules can also prevent a sugar tolerance patient and a potential diabetic patient (who is fat, has strong genetic background and has irregular living habits) from being converted into a diabetic patient; and the luffa seeds or the luffa seed capsules also has a good treating effect on complications (foot diseases in diabetes) of diabetes mellitus.
Owner:江苏晶红生物医药科技股份有限公司

Nutritional product with steady blood sugar regulation function, preparation method and application thereof

The invention discloses a preparation method of a nutritional product with steady blood sugar regulation function. The method comprises the processes of: taking mulberries and oat as the main raw materials, and subjecting the materials to sterilization, inoculation, composite bacteria mixed fermentation, single bacterium continuous fermentation, adding of auxiliary materials, drying molding, and packaging and sterilization, thus obtaining the nutritional product. The preparation method is completed under medium and low temperature conditions, can effectively avoid the change of polyhydroxylated alkaloids, flavones, polysaccharide and other natural active ingredients in mulberries and oat, and maximumly keeps the nutrition and flavor components peculiar to mulberries and oat. The invention also discloses the nutritional product with steady blood sugar regulation function, and the nutritional product is rich in polyhydroxylated alkaloids, flavones, polysaccharide and other natural active ingredients. The invention also discloses application of the nutritional product with steady blood sugar regulation function in health food with diabetes prevention and/or treatment efficacy.
Owner:SERICULTURE & AGRI FOOD RES INST GUANGDONG ACAD OF AGRI SCI +1

A microneedle patch for intelligently regulating blood sugar and its preparation method

The invention discloses a microneedle patch for intelligently regulating blood sugar and a preparation method thereof, belonging to the field of biomedicine. The intelligent microneedle part of the microneedle patch for regulating blood sugar of the present invention is filled with the medicine for intelligently regulating blood sugar, the medicine carrier material, the sensitive switch factor of glucose response, and the medicine molecule. Fill the drug-containing hydrogel solution into the microneedles of the microneedle template by vacuuming and centrifuging; and prepare the base of the microneedle patch with the drug-free hydrogel solution by centrifuging again, The hydrogel material is solidified by a suitable method, and after drying, the microneedle patch is peeled off from the template to obtain a microneedle patch for intelligently regulating blood sugar. The microneedle patch of the present invention can puncture the skin, and intelligently release the contained insulin in the body according to the blood sugar concentration, so as to intelligently regulate the blood sugar level. Through the invention, painless, intelligent response blood sugar regulation is realized, and it is expected to guide the integration of diagnosis and treatment of diabetes.
Owner:WUHAN UNIV

Ganoderma pill and processing method thereof

The invention provides a ganoderma pill and a processing method thereof, belonging to the processing field of ganoderma. With an alcohol-extracted ganoderma extract as the main material and shell-broken ganoderma lucidum spore powder as the auxiliary material, the processing technique comprises the following steps of: choosing the alcohol-extracted ganoderma extract subjected to ethanol tower type gradient diacolation extraction and the shell-broken ganoderma lucidum spore powder; stirring and uniformly mixing by using a stirring machine, making into pills, drying, packaging with coating outside the pills, cooling and sizing to obtain the ganoderma pills. The ganoderma pill disclosed by the invention solves a problem that the content of the effective component of the ganoderma contained in the traditional product is low; in particular, the content of the special triterpene matter in the ganoderma is increased, so that the action time on human bodies is prolonged, the effects of lowering blood pressure and decreasing blood sugar are improved, the body's immunity is regulated, the anti-anaphylaxis and the sleeping quality are improved. The ganoderma pill solves the problems that the ganoderma pill in the prior art is big in dosage, unobvious in pharmacodynamic effects, long in effect-initiating time and poor in taste.
Owner:毛景华

Propolis soft capsule and production process thereof

The present invention relates to a propolis soft capsule and a production process thereof. The formula comprises: 720 g of propolis powder, 430 g of bee milk lyophilized powder, 50 g of a lobed kudzuvine root extract, and 2800 g of olive oil, wherein the materials are made into 10000 soft capsules, and the weight of every soft capsule is 0.4 g. The production process comprises: weighing the propolis powder, the bee milk lyophilized powder and the lobed kudzuvine root extract according to the raw material ratio in the formula, respectively screening with a 120 mesh sieve, completely mixing, weighing the olive oil according to the amount in the formula, placing into a stainless steel material preparing pot, heating to a temperature of 60 DEG C, mixing the heated olive oil and the mixture obtained from the previous step, milling three times with a colloid mill, drawing bubbles, cooling to a room temperature to be spare, and carrying out pill pressing, pill selection, pill washing, drying and packaging. The propolis soft capsule has double effects of blood sugar regulation and blood lipid regulation. The process adopts the most advanced low temperature extracting, low temperature extraction, freezing, vacuum drying and other advanced technologies so as to ensure preservation of biological activity of effective components of the product at a maximum, such that an effect is good.
Owner:李是

Medication for treating diabetes

InactiveCN1660235AReduce or eliminate insulin resistanceProtect and restore islet functionMetabolism disorderSuppositories deliveryDrugNavel
A Chinese medicine in the form of capsule, navel plaster and suppository for treating diabetes is proportionally prepared from 11 Chinese-medicinal materials including mulberry twig, astragalus root, red sage root, Chuan-xiong rhizome, etc.
Owner:中国人民解放军海军青岛疗养院

Traditional Chinese medicine for reducing blood sugar, governing blood fat and anti-DNA damnification, and preparation method thereof

The invention relates to a method for preparing a traditional Chinese medicine for reducing blood sugar, adjusting blood fat and resisting DNA injury. 10 to 15 grams of red ginseng and 5 to 7.5 grams of panax notoginseng are taken out and are pulverized to fine powders for standby; 25 to 30 grams of radix astragali, 10 to 15 grams of phellodendron, 10 to 15 grams of coptis root , 15 to 20 grams of salvia miltiorrhiza, 10 to 15 grams of red paeony root, 15 to 20 grams of kudzu root and 10 to 15 grams of shizandra are added with 60-80 mass percent ethanol; the addition amount of the ethanol is 8 to 10 times of the amount of a raw medicinal material; the mixture is subjected to refluxing extraction for 2 to 3 times; each time is kept for 2 to 3 hours; the mixture is filtered; filtrate is combined, ethanol is reclaimed in reduced pressure, and the filtrate after the reclaim of the ethanol is condensed into an extract with the relative density of between 1.10 and 1.15 at the temperature of 40 DEG C; the extract is used for standby; 25 to 35 grams of sealwort, 15 to 20 grams of medlar, 3 to 5 grams of rhubarb and medicine residue after ethanol extraction are added with water the amount of which is 8 to 10 times of the total amount of the sealwort, the medlar, the rhubarb and the medicine residue, and are subjected to refluxing extraction for 2 to 3 times; each time is kept for 2 hours; the extract is filtered; filtrate is combined and condensed into an extract with the relative density of between 1.10 and 1.15 at the temperature of 40 DEG C; the ethanol extracted extract are combined, sprayed and dried; the temperature of an inlet is between 140 and 160 DEG C; and the extract is added with 10 to 15 grams of fine powders of the red ginseng, 5 to 7.5 grams of fine powders of the panax notoginseng and proper amount of calcium carbonate to prepare a granular formulation. The Chinese medicine preparation can obviously reduce blood sugar, adjust blood fat, resist DNA injury.
Owner:LIAONING UNIV OF TRADITIONAL CHINESE MEDICINE

Application of pectolinarin in preparation of medicine for treating glucolipid metabolism diseases and medicinal composition

The invention belongs to the technical field of medicines, and particularly relates to application of pectolinarin in preparation of a medicine for treating glycolipid metabolism diseases and a medicinal composition. According to the application of the pectolinarin in preparation of the medicine for treating the glycolipid metabolism diseases, experiments prove that the pectolinarin has the effects of reducing blood sugar of mice suffering from glycolipid metabolism disorder, regulating blood fat, reducing weight and reducing abdominal girth, can also promote L cells of intestinal tracts of the mice to secrete hypoglycemic hormone GLP-1 to achieve the effect of enhancing the insulin sensitivity, and can effectively treat the glycolipid metabolism diseases. The invention also provides the medicinal composition containing the pectolinarin. The medicinal composition comprises the pectolinarin and atractylenolide I. Compared with the pectolinarin, the medicinal composition has the advantages that the blood sugar is reduced, the blood fat is regulated, the effect of promoting the intestinal L cells to secrete the hypoglycemic hormone GLP-1 is more remarkable, and the medicinal composition has a good application prospect in the aspect of treating the glycolipid metabolism diseases.
Owner:GUANGDONG PHARMA UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products